# FDA Inspection 1007571 - Bioelements Inc. - February 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/bioelements-inc/8cafddf0-9e1a-4c4d-9a5f-32a91d240e5c
Source feed: FDA_Inspections

> FDA Inspection 1007571 for Bioelements Inc. on February 10, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007571
- Company Name: Bioelements Inc.
- Inspection Date: 2017-02-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155328 - 2021-10-27](https://www.keypedia.com/records/fda_inspections/bioelements-inc/863a56d2-8a03-4146-bf20-6f2d705656f6)
- [FDA Inspection 1007571 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/bioelements-inc/e3be4bd3-4571-4554-bed9-a1562bb80570)
- [FDA Inspection 797685 - 2012-09-06](https://www.keypedia.com/records/fda_inspections/bioelements-inc/506d5543-c819-4060-a1bf-d5047c3f0be6)
- [FDA Inspection 645568 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/bioelements-inc/6ae1d43e-615d-47e1-9509-751905c54560)

Company: https://www.keypedia.com/companies/bioelements-inc/7257e8b0-bd4b-4eda-a8a2-80e51a2e9365

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c